The p53 oncogene is present in elevated levels in many tumor cells. In tissue culture, p53 cooperates with an activated ras gene to transform rat fibroblasts. Furthermore, p53 is a necessary cellular component of SV40 T antigen mediated transformation. Recently, p53 was found to bind a cellular protein, hsc70. The role of p53, whether it be a critical factor in mediating transformation or whether it be a consequence of the transformed state and simply needed for growth, remains unclear. Therefore, in order to study the effects of overexpression of p53 and its interaction with T antigen and hsc70, several p53 constructs will be introduced into mouse embryos. One of these constructs encodes a mutant p53 cDNA with an in frame linker at amino acid 215 which no longers binds T antigen, but does bind hsc70 and has an increased transformation potential in tissue culture compared to its parent cDNA. The level of expression of p53 mRNA and protein and the tissue specificity will be determined. In addition, p53 transgenic mice will be mated with mice expressing T antigen to determine the effects of p53 gene product on the development of brain tumors in these transgenic mice. The levels of hsc70 in tissues expressing p53 and the interaction of these proteins will be examined in vivo using transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA047296-03
Application #
3458898
Study Section
Pathology B Study Section (PTHB)
Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Tashakori, Mehrnoosh; Zhang, Yun; Xiong, Shunbin et al. (2016) p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis. Mol Cancer Res 14:56-65
Riley, M F; You, M J; Multani, A S et al. (2016) Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma. Oncogene 35:358-65
Pant, Vinod; Lozano, Guillermina (2014) Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev 28:1739-51
Zhang, Yun; Xiong, Shunbin; Li, Qin et al. (2014) Tissue-specific and age-dependent effects of global Mdm2 loss. J Pathol 233:380-91
Li, Qin; Zhang, Yun; El-Naggar, Adel K et al. (2014) Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors. Mol Cancer Res 12:901-11
Pant, Vinod; Lozano, Guillermina (2014) Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity. Oncotarget 5:1149-56
Li, Qin; Lozano, Guillermina (2013) Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy. Clin Cancer Res 19:34-41
Pant, Vinod; Xiong, Shunbin; Jackson, James G et al. (2013) The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity. Genes Dev 27:1857-67
Pant, Vinod; Quintás-Cardama, Alfonso; Lozano, Guillermina (2012) The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans. Blood 120:5118-27
Jackson, James G; Pant, Vinod; Li, Qin et al. (2012) p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell 21:793-806

Showing the most recent 10 out of 13 publications